Scholarlink

Background <p>Flea infestations remain a major issue in veterinary medicine. Highly effective flea control for dogs and cats remains the foundation for eliminating infestations from homes and improving skin conditions associated with flea-feeding.</p> Methods <p>Homes with pet cats were screened by flea-history questionnaire. Qualifying homes were subselected into “high” (≥ 5 fleas on ≥ 1 cat, and ≥ 5 fleas collected in environmental flea traps over a 16–24&#xa0;h period), “low” (&lt; 5 fleas on all cats, &lt; 5 in traps), and “no” homes (no evidence of fleas on cats or traps). All cats and dogs in a household were treated with a lotilaner oral tablet (Credelio<sup>®</sup> CAT and Credelio<sup>®</sup>, respectively) in weeks 0, 4, and 8. On-animal and trap counts were performed for: “high” at weeks 0, 1, 2, 4, 6, 8, and 11–12; “low” at week 0 and at approximately 2-week intervals through week 11–12; and “no” only at week 0. During each visit, one owner completed a pruritus assessment (PVAS) and a veterinary dermatologist assessed dermatologic lesions using the feline allergic dermatitis (SCORFAD) scale.</p> Results <p>A total of 46 homes met inclusion criteria and completed the study: 19 “high” (35 cats); 17 “low” (27); and 10 “no” (14). By week 1, relative to pretreatment, there was a 99.3% reduction in flea counts on “high” cats, with 31 of 34 cats (91.2%) flea-free. By week 11–12, flea counts across all study cats and traps were zero. Prior to the first treatment, mean PVAS scores were: “high” 6.6; “low” 5.5; and “no” 1.9. By week 1 there was a significant decrease in mean PVAS score of cats from “high” homes to 2.9 (<i>P</i> &lt; 0.0001), and mean week 11–12 scores were 0.5 and 0.8 for “high” and “low” homes, respectively. For SCORFAD, by week 11–12, relative to week 0, there was a significant decline in mean scores of cats from both “high” (8.0 to 1.7) (<i>P</i> &lt; 0.0001) and “low” homes (3.3 to 0.9) (<i>P</i> &lt; 0.0001).</p> Conclusions <p>Lotilaner was 100% efficacious in eliminating flea infestations from animals and their homes. The monthly lotilaner treatments of cats and dogs in flea-infested homes resulted in clinical resolution of pruritus and dermatologic lesions.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assessment of lotilaner (Credelio® CAT) for control of in-home Ctenocephalides felis infestations

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月14日

查看全文
  • Cameron Sutherland,
  • Trey Tomlinson,
  • Grace Wilson,
  • Amiah Gray,
  • Kamilyah Miller,
  • Taylor Gin,
  • Erin Lashnits,
  • Yiyao Li,
  • Todd M. Kollasch,
  • Casey L. Locklear,
  • William G. Ryan,
  • Michael Canfield,
  • Brian H. Herrin

摘要

Background

Flea infestations remain a major issue in veterinary medicine. Highly effective flea control for dogs and cats remains the foundation for eliminating infestations from homes and improving skin conditions associated with flea-feeding.

Methods

Homes with pet cats were screened by flea-history questionnaire. Qualifying homes were subselected into “high” (≥ 5 fleas on ≥ 1 cat, and ≥ 5 fleas collected in environmental flea traps over a 16–24 h period), “low” (< 5 fleas on all cats, < 5 in traps), and “no” homes (no evidence of fleas on cats or traps). All cats and dogs in a household were treated with a lotilaner oral tablet (Credelio® CAT and Credelio®, respectively) in weeks 0, 4, and 8. On-animal and trap counts were performed for: “high” at weeks 0, 1, 2, 4, 6, 8, and 11–12; “low” at week 0 and at approximately 2-week intervals through week 11–12; and “no” only at week 0. During each visit, one owner completed a pruritus assessment (PVAS) and a veterinary dermatologist assessed dermatologic lesions using the feline allergic dermatitis (SCORFAD) scale.

Results

A total of 46 homes met inclusion criteria and completed the study: 19 “high” (35 cats); 17 “low” (27); and 10 “no” (14). By week 1, relative to pretreatment, there was a 99.3% reduction in flea counts on “high” cats, with 31 of 34 cats (91.2%) flea-free. By week 11–12, flea counts across all study cats and traps were zero. Prior to the first treatment, mean PVAS scores were: “high” 6.6; “low” 5.5; and “no” 1.9. By week 1 there was a significant decrease in mean PVAS score of cats from “high” homes to 2.9 (P < 0.0001), and mean week 11–12 scores were 0.5 and 0.8 for “high” and “low” homes, respectively. For SCORFAD, by week 11–12, relative to week 0, there was a significant decline in mean scores of cats from both “high” (8.0 to 1.7) (P < 0.0001) and “low” homes (3.3 to 0.9) (P < 0.0001).

Conclusions

Lotilaner was 100% efficacious in eliminating flea infestations from animals and their homes. The monthly lotilaner treatments of cats and dogs in flea-infested homes resulted in clinical resolution of pruritus and dermatologic lesions.

Graphical abstract